The significance of 5-hydroxytryptamine for insulin secretion in the mouse.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001966:Bromine / Q000494:pharmacology; D004336:Drug Antagonism; D005947:Glucose / Q000494:pharmacology; D006943:Hyperglycemia / Q000378:metabolism; D066298:In Vitro Techniques; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000166:cytology / Q000378:metabolism; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009526:Nialamide / Q000494:pharmacology; D009765:Obesity / Q000378:metabolism; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000502:physiology*; D012702:Serotonin Antagonists
D007328:Insulin; D008996:Monoamine Oxidase Inhibitors; D012702:Serotonin Antagonists; D012701:Serotonin; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D006916:5-Hydroxytryptophan; D005947:Glucose; D001966:Bromine; D009526:Nialamide